Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2010
10/28/2010WO2010123083A1 Polypeptide derived from mouse hepatitis virus and/or polypeptide derived from sendai virus, test kit for infection by mouse hepatitis virus and/or sendai virus using the polypeptide, and method for detecting infection by mouse hepatitis virus and/or sendai virus
10/28/2010WO2010123080A1 Method for producing soluble sr-a protein and evaluation method using same
10/28/2010WO2010123065A1 Cancer antigen helper peptide
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010122460A1 Control of protein glycosylation and compositions and methods relating thereto
10/28/2010WO2010122378A1 Method for chondrogenic differentiation of pluripotent or multipotent stem cells using wnt6
10/28/2010WO2010122367A2 Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
10/28/2010WO2010122245A1 Bleaching peptide hydrolysate proteasome activator and compositions containing same
10/28/2010WO2010122244A1 Peptide hydrolysate proteasome activators and compositions containing same
10/28/2010WO2010122217A1 A novel cell and therapeutical and diagnostical methods based thereon
10/28/2010WO2010122181A1 Oligomeric proteins and the uses thereof
10/28/2010WO2010122090A1 Fgfr1c antibody combinations
10/28/2010WO2010121714A1 Complexes between phospholipids and protein vimentin, and in vitro methods for the detection of antibodies against these complexes
10/28/2010WO2010121618A1 A tuberculosis tb vaccine to prevent reactivation
10/28/2010WO2010121559A1 Novel exendin variant and conjugate thereof
10/28/2010WO2010121533A1 Rape heat shock protein gene hsp17.8 and uses thereof
10/28/2010WO2010121352A1 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy
10/28/2010WO2010121351A1 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy
10/28/2010WO2010121288A1 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR α-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR α-CHAIN
10/28/2010WO2010091262A8 Chimeric newcastle disease viruses and uses thereof
10/28/2010WO2010087997A3 Cell lines expressing guanylate cyclase-c and methods of using them
10/28/2010WO2010078325A3 Natriuretic polypeptides for reducing or preventing restenosis
10/28/2010WO2010078045A3 Method of making small liposomes
10/28/2010WO2010058428A3 Identification of genes related to abiotic stress tolerance in jatropha curcas
10/28/2010WO2010042751A3 Chimeric therapeutics, compositions, and methods for using same
10/28/2010WO2010042749A3 Chimeric therapeutics, compositions, and methods for using same
10/28/2010WO2010042743A3 Chimeric multiplexes, compositions, and methods for using same
10/28/2010WO2010034514A3 Cfhr1 as a c5 convertase inhibitor for the treatment of autoimmune diseases
10/28/2010WO2010018378A8 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
10/28/2010WO2009003074A9 Cholinergic/serotoninergic chimeric receptor and uses thereof
10/28/2010US20100275333 Abiotic stress responsive polynucleotides and polypeptides
10/28/2010US20100275321 Generation of plants with improved pathogen resistance and drought tolerance
10/28/2010US20100275284 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
10/28/2010US20100275281 Multiple Inducible Gene Regulation System
10/28/2010US20100275280 Method for identifying, expanding and removing adult stem cells and cancer stem cells
10/28/2010US20100275279 Selecting animals for parentally imprinted traits
10/28/2010US20100273996 Method
10/28/2010US20100273995 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin B and related compounds
10/28/2010US20100273992 Method for the production of an immunostimulating mucin (muc1)
10/28/2010US20100273991 Method of covalently modifying proteins with organic molecules to prevent aggregation
10/28/2010US20100273990 Notch-based fusion proteins and uses thereof
10/28/2010US20100273987 Soybean Cultivar 89146110
10/28/2010US20100273986 Post-translational modification and clostridial neurotoxins
10/28/2010US20100273985 Post-translational modifications and clostridial neurotoxins
10/28/2010US20100273983 Method of purifying peptides by selective precipitation
10/28/2010US20100273981 Use of Silintaphin for the Structure-Directed Fabrication of (Nano)Composite Materials in Medicine and (Nano)Technology
10/28/2010US20100273980 Fungal pepc inhibitor
10/28/2010US20100273979 Compositions, methods and uses
10/28/2010US20100273978 Modified polypeptides suitable for acceptace of amino acid substited molecules
10/28/2010US20100273866 Diagnosis and treatment of cancer: i
10/28/2010US20100273722 Modified miniature proteins
10/28/2010US20100273718 Milk Protein Hydrolyzates with Reduced Immunogenic Potential
10/28/2010US20100273710 Highly Potent Full and Partial Agonists and Antagonists of the Nociceptin/Orphanin FQ Receptor
10/28/2010US20100273707 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273704 Methods of modulating cellular homeostatic pathways and cellular survival
10/28/2010US20100273702 Chimerical peptidic molecules with antiviral properties against the viruses of the flaviviridae family
10/28/2010US20100273669 Method for selecting a peptide or polypeptide which binds to a target
10/28/2010US20100273274 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
10/28/2010US20100273265 for inducing differentiation into retinal photoreceptor cells; for preventing/treating/suppressing progression of retinal diseases; retinitis pigmentosa, senile macular degeneration, diabetic retinopathy, retinal detachment, glaucoma and retinal vessel occlusion
10/28/2010US20100273257 Apo-2DcR
10/28/2010US20100273256 Human Potassium Channel Genes
10/28/2010US20100273240 Method for production and purification of macromolecular complexes
10/28/2010US20100273238 Cellular Permissivity Factor for Viruses and Uses Thereof
10/28/2010US20100273234 Process for obtaining bioactive recombinant protein from inclusion bodies
10/28/2010US20100273233 Amyloid specific peptides and uses thereof
10/28/2010US20100273212 PP1 Ligands
10/28/2010US20100273202 Codon-optimized nucleic acid for coding apo-clytin-ii and method for using the same
10/28/2010US20100273194 Immunoreactive ehrlichia p120/p140 epitopes and uses thereof
10/28/2010US20100273193 Triacetone Triperoxide and Diacetone Diperoxide Derivatives, Method for the Preparation and Use Thereof
10/28/2010US20100273190 Pkhdl1, a homolog of the autosomal recessive kidney disease gene
10/28/2010US20100273187 Antibodies against delta-5 desaturase and uses thereof
10/28/2010US20100273174 Antibodies to tumor associated proteins
10/28/2010US20100273161 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin
10/28/2010US20100273158 HIN-1, A Tumor Suppressor Gene
10/28/2010US20100273145 Assay method utilizing polynucleotide sequences
10/28/2010US20100272855 Hybrid alpha-glucoside transporter
10/28/2010US20100272817 Compositions and Methods for Treating Atherosclerosis
10/28/2010US20100272788 Vaccines for malaria
10/28/2010US20100272761 Synthesis of lipoamide-grafted high molecular compound and method therefor
10/28/2010US20100272760 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
10/28/2010US20100272757 Bacillus anthracis protective antigen nucleic acid sequences
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272751 Truncated l1 protein of human papillomavirus type 18
10/28/2010US20100272749 Optimized expression of HPV 58 L1 in yeast
10/28/2010US20100272746 Lipoparticle comprising a protein and methods of making and using the same
10/28/2010US20100272744 OMP85 Proteins of Neisseria Gonorrhoeae and Neisseria Meningitidis, Compositions Containing Same and Methods of Use Thereof
10/28/2010US20100272743 Staphylococcus epidermidis nucleic acids and proteins
10/28/2010US20100272742 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
10/28/2010US20100272741 Immunity to folate receptors
10/28/2010US20100272739 Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272727 Compound for controlling appetite
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272725 Neisserial antigens
10/28/2010US20100272707 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof
10/28/2010US20100272688 Method of treating or retarding the development of blindness
10/28/2010US20100272647 Receptor
1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 2916